Shopping Cart 0
Cart Subtotal
AED 0

Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Atreca Inc (Atreca) is a biotechnology company that develops and develops novel therapies based on the human immune response. The company develops proprietary immune repertoire capture technology that act as an engine for the discovery and development of antibody based therapeutics, diagnostics, vaccines and research reagents. Its technology has partnerships with pharmaceutical companies, academic institutions, non-profit foundations and governmental entities. Its pipeline products are intended for the treatment of breast tumor, lung tumor, colon tumor and other solid tumors. Atreca is headquartered in Redwood City, California, the US.

Atreca Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9

Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Atreca Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Atreca Raises USD125 Million in Series C Venture Financing 12

Atreca Raises USD35 Million in Series B Financing 14

Atreca Raises USD56 Million in Series A Financing 15

Atreca Raises USD57.26 Million in Venture Financing 16

Atreca Raises USD0.7 Million in Venture Financing 17

Atreca Raises USD0.05 Million in Venture Financing 18

Atreca Raises USD3 Million in Venture Financing 19

Atreca Raises Funds through Venture Financing 20

Atreca Raises USD0.4 Million in Venture Financing 21

Partnerships 22

Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22

Atreca Enters into Agreement with Genome Institute of Singapore 23

Atreca Enters into Research Agreement with Janssen Biotech 24

Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25

Licensing Agreements 26

Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26

Atreca Inc-Key Competitors 27

Atreca Inc-Key Employees 28

Atreca Inc-Locations And Subsidiaries 29

Head Office 29

Recent Developments 30

Corporate Communications 30

Apr 19, 2018: Atreca Names John A. Orwin As President and CEO 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Atreca Inc, Pharmaceuticals & Healthcare, Key Facts 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Atreca Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9

Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Atreca Raises USD125 Million in Series C Venture Financing 12

Atreca Raises USD35 Million in Series B Financing 14

Atreca Raises USD56 Million in Series A Financing 15

Atreca Raises USD57.26 Million in Venture Financing 16

Atreca Raises USD0.7 Million in Venture Financing 17

Atreca Raises USD0.05 Million in Venture Financing 18

Atreca Raises USD3 Million in Venture Financing 19

Atreca Raises Funds through Venture Financing 20

Atreca Raises USD0.4 Million in Venture Financing 21

Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22

Atreca Enters into Agreement with Genome Institute of Singapore 23

Atreca Enters into Research Agreement with Janssen Biotech 24

Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25

Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26

Atreca Inc, Key Competitors 27

Atreca Inc, Key Employees 28

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Atreca Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Atreca Inc (Atreca) is a biotechnology company that develops and develops novel therapies based on the human immune response. The company develops proprietary immune repertoire capture technology that act as an engine for the discovery and development of antibody based therapeutics, diagnostics, vaccines and research reagents. Its technology has partnerships with pharmaceutical companies, academic institutions, non-profit foundations and governmental entities. Its pipeline products are intended for the treatment of breast tumor, lung tumor, colon tumor and other solid tumors. Atreca is headquartered in Redwood City, California, the US.

Atreca Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9

Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Atreca Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Atreca Raises USD125 Million in Series C Venture Financing 12

Atreca Raises USD35 Million in Series B Financing 14

Atreca Raises USD56 Million in Series A Financing 15

Atreca Raises USD57.26 Million in Venture Financing 16

Atreca Raises USD0.7 Million in Venture Financing 17

Atreca Raises USD0.05 Million in Venture Financing 18

Atreca Raises USD3 Million in Venture Financing 19

Atreca Raises Funds through Venture Financing 20

Atreca Raises USD0.4 Million in Venture Financing 21

Partnerships 22

Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22

Atreca Enters into Agreement with Genome Institute of Singapore 23

Atreca Enters into Research Agreement with Janssen Biotech 24

Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25

Licensing Agreements 26

Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26

Atreca Inc-Key Competitors 27

Atreca Inc-Key Employees 28

Atreca Inc-Locations And Subsidiaries 29

Head Office 29

Recent Developments 30

Corporate Communications 30

Apr 19, 2018: Atreca Names John A. Orwin As President and CEO 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Atreca Inc, Pharmaceuticals & Healthcare, Key Facts 2

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Atreca Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9

Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Atreca Raises USD125 Million in Series C Venture Financing 12

Atreca Raises USD35 Million in Series B Financing 14

Atreca Raises USD56 Million in Series A Financing 15

Atreca Raises USD57.26 Million in Venture Financing 16

Atreca Raises USD0.7 Million in Venture Financing 17

Atreca Raises USD0.05 Million in Venture Financing 18

Atreca Raises USD3 Million in Venture Financing 19

Atreca Raises Funds through Venture Financing 20

Atreca Raises USD0.4 Million in Venture Financing 21

Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22

Atreca Enters into Agreement with Genome Institute of Singapore 23

Atreca Enters into Research Agreement with Janssen Biotech 24

Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25

Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26

Atreca Inc, Key Competitors 27

Atreca Inc, Key Employees 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Atreca Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.